Electronic Journal of General Medicine

• Grosheide P. Van Damme P. Prevention and control of hepatitis B in the community, WHO Viral Hepatitis Prevantion Board, Communnicable Diseasse Series No.1. 1996, Edegen, Belgium.
• Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat 2004; 11(2):97-107
• Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005;2(1):50–7
• Mahoney FC. Update on diagnosis management and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999;12:351-66
• Update: Vaccine Side Effects, Adverse Reactions, Contraindications, and Precautions Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45(RR12):1-35
• Lilic D, Ghosh SK. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet 1994; 344 (5):1292.
• Ballinger AB, Clark ML. Acute hepatitis B infection after vaccination. Lancet 1994;345:262
• Aggarwal R, Ranjan P. Preventing and treating hepatitis B infection. BMJ 2004;329;1080-86
• Koziel MJ, Siddiqui A. Hepatitis B virus and hepatitis Delta virus. In: Mandell GL, Douglas RG, Bennett JE (eds). Principles and practice of infectious disease. 6th ed. Philadelphia: Churchill Livingstone, 2005;1864-90
• Pincus MR, Schaffer JA. Assesment of liver function. In: John Bernard Henry, ed. Clinical Diagnosis and Management By Laboratory Methods. 20th ed.,W.B. Saunders Company, 2001; 253-67
• Prescribing Information. Aventis Pasteur, Lyon, France, 2003, License No 69007
• Csepregi A, Treiber G, Röcken C, Malfertheiner P. Acute exacerbation of autoimmune hepatitis induced by Twinrix. World J Gastroenterol 2005; 11(26):4114-16
• Prescribing Information. GlaxoSmithKline, Rixensart, Belgium, 2003, US License No 1617
• Ballinger AB, Clark ML. Severe acute hepatitis B infection after vaccination. Lancet 1994; 344 (5):12
• Goffin E, Horsmans Y, Cornu C, Geubel A, Pirson Y. Acute hepatitis B infection after vaccination. Lancet 1995; 345:263
• Brezin A, Lautier-Frau M, Hamedani M, Rogeaux O, Hoang PL. Visual loss andeosinophilia after recombinant hepatitis B vaccine. Lancet 1993;342: 563–4

Vancouver

Önlen Y, Savaş L, Özer B, İris NE. THE ELEVATION OF LIVER ENZYMES DUE TO HEPATITIS B VACCINE. EUR J GEN MED. 2006;3(4):197-200. https://doi.org/10.29333/ejgm/82411

APA

Önlen, Y., Savaş, L., Özer, B., & İris, N. E. (2006). THE ELEVATION OF LIVER ENZYMES DUE TO HEPATITIS B VACCINE. European Journal of General Medicine, 3(4), 197-200. https://doi.org/10.29333/ejgm/82411

AMA

Önlen Y, Savaş L, Özer B, İris NE. THE ELEVATION OF LIVER ENZYMES DUE TO HEPATITIS B VACCINE. EUR J GEN MED. 2006;3(4), 197-200. https://doi.org/10.29333/ejgm/82411

Chicago

Önlen, Yusuf, Lütfü Savaş, Burçin Özer, and Nur Efe İris. "THE ELEVATION OF LIVER ENZYMES DUE TO HEPATITIS B VACCINE". European Journal of General Medicine 2006 3 no. 4 (2006): 197-200. https://doi.org/10.29333/ejgm/82411

Harvard

Önlen, Y., Savaş, L., Özer, B., and İris, N. E. (2006). THE ELEVATION OF LIVER ENZYMES DUE TO HEPATITIS B VACCINE. European Journal of General Medicine, 3(4), pp. 197-200. https://doi.org/10.29333/ejgm/82411

MLA

Önlen, Yusuf et al. "THE ELEVATION OF LIVER ENZYMES DUE TO HEPATITIS B VACCINE". European Journal of General Medicine, vol. 3, no. 4, 2006, pp. 197-200. https://doi.org/10.29333/ejgm/82411